MALISSA PAXTON: Open Payments
NPI 1144321902 · DERBY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,768 in 90 payments from 18 companies in 2025. Trend: 2023 $1,011 · 2024 $1,010 · 2025 $1,768
Food & beverage: $1,768
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $317 |
| PFIZER INC. | 14 | $219 |
| AstraZeneca Pharmaceuticals LP | 5 | $185 |
| ABBVIE INC. | 15 | $168 |
| Dexcom, Inc. | 2 | $134 |
| Lilly USA, LLC | 7 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $97 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Exact Sciences Corporation | 5 | $72 |
Products named: Wegovy, BREZTRI, QULIPTA, DEXCOM G7 GSS (161), NURTEC ODT, ZAVZPRET, Kerendia, CAPLYTA.
Industry payments across KS — which companies pay providers there.
